LYLijun Yang

Lijun Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lijun Yang has a total of 101 co-authors. Here are the top co-authors by number of shared publications:

  • Yan Chen

    Department of Neurosurgery The Second Hospital of Hebei Medical University Shijiazhuang Hebei China

    3 shared publications
  • Bin Li

    Department of Neurosurgery North China Oilfield General Hospital Renqiu China

    2 shared publications
  • Erwei Zhang

    Department of Neurosurgery The Second Hospital of Hebei Medical University Shijiazhuang Hebei China

    2 shared publications
  • Meng Wang

    Department of Neurosurgery The Second Hospital of Hebei Medical University Shijiazhuang Hebei China

    2 shared publications
  • Zhenzeng Fan

    Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China

    2 shared publications
  • Baowei Ha

    32 Liaocheng No. 4 Hospital, Liaocheng, Shandong, P.R. China

    1 shared publication

Latest Publications

  • Open Access

    Astrocyte‐Derived Exosomal miR ‐211‐5p Alleviates Blood–Brain Barrier Injury in a Rat Model of Traumatic Brain Injury

    by Yan Chen, Xuan Yin, Erwei Zhang, Bin Li, Huijie Yu, Jiawang Qi, Minghao Liu, Meng Wang, Zhenzeng Fan, Lijun Yang

    Background: Traumatic brain injury (TBI) triggers a cascade of secondary damage, including neuroinflammation, astrocyte activation, and disruption of the blood–brain barrier (BBB), all of which contribute to long‐term neurological deficits. Astrocyte‐derived exosomes have emerged as a promising therapeutic avenue; however, the specific contributions of their molecular cargo remain poorly understood. This study explores whether astrocyte‐derived exosomal delivery of microRNA‐211‐5p (miR‐211‐5p) can attenuate secondary injury and enhance functional recovery following TBI. Methods: Primary astrocytes were transfected with AAV‐rno‐miR‐211‐5p, and the resulting exosomes were isolated and characterized. TBI was induced in adult rats using a controlled cortical impact (CCI) model. Exosomes (1 × 10 11 particles) were administered intravenously 30 min post‐injury. Behavioral assessments were conducted to evaluate cognitive function and neurological deficits. Brain edema, glial activation, and the expression of inflammatory cytokines (IL‐6, IL‐1β, TNF‐α) and BBB‐related markers—including glial fibrillary acidic protein (GFAP), matrix metalloproteinase 9 (MMP9), aquaporin 4 (AQP4), and the tight junction proteins zonula occludens‐1 (ZO‐1) and claudin‐5—were analyzed using quantitative real‐time PCR, Western blotting, enzyme‐linked immunosorbent assay, and histopathological techniques. Results: Exosomes enriched with miR‐211‐5p significantly improved cognitive and neurological outcomes, reduced cerebral edema, and downregulated the expression of GFAP, MMP9, and AQP4. Furthermore, the integrity of the BBB was preserved, as evidenced by sustained expression of ZO‐1 and claudin‐5. Levels of the proinflammatory cytokines IL‐6, IL‐1β, and TNF‐α were also markedly decreased in the injured cortex. Conclusion: Astrocyte‐derived exosomal miR‐211‐5p confers neuroprotection in TBI by modulating glial activation, reducing neuroinflammation, and preserving BBB integrity. These findings underscore the therapeutic potential of miR‐211‐5p‐loaded exosomes as a cell‐free, targeted intervention for brain trauma.


  • Comparison of brainstem hematoma volume evaluation techniques with a novel quantitative approach

    by Xiangdong Wan, Yan Chen, Xueke Zhen, Ziqian Yan, Ziyi Liu, Tianxu Pang, Erwei Zhang, Zhenzeng Fan, Lijun Yang

    This study systematically compares various methods for calculating brainstem hematoma volume, and introduces a novel estimation method based on the maximum cross-sectional area. First, we assessed the accuracy of the Tada formula and 3D Slicer software for quantifying brainstem hematomas of different sizes and morphologies. The results revealed significant differences among methods, with the traditional Tada formula frequently overestimating hematoma volumes. We therefore propose an improved algorithm that substantially increases both the accuracy and reliability of hematoma volume assessment. Experimental results demonstrate that this new method provides greater precision and consistency when measuring the volume of irregular hematomas. These findings not only contribute to improved diagnosis and treatment of brainstem hemorrhage but also provide valuable support for future research and practical applications.

  • miR-211-5p targeting MMP9 regulates the expressions of AQP4 in traumatic brain injury

    by Meng Wang, Xin Yu, Bin Li, Chensong Gao, Yan Chen, Xiaoyang Zhang, Wenling Li, Lijun Yang, Zhenzeng Fan

    Objective The abnormal expression of matrix metalloproteinase 9 (MMP9) and Aquaporin 4 (AQP4) closely associates with the traumatic brain injury (TBI) development. Methods Here, we investigated the relationship between miR-211-5p and MMP9/AQP4 axis in TBI patients and astrocyte cells. Demographics, clinical features, and cerebrospinal fluid (CSF) samples were collected from traumatic brain injury (TBI) patients (n = 96) and controls (n = 30) for pathological and gene expression analyses. Luciferase activity assay and gene expression analyses were performed to dissect the regulatory mechanism of miR-211-5p on MMP9/AQP4 in human astrocyte cells. Results miR-211-5p mRNA was significantly decreased in the CSF of TBI patients, which positively correlated with the expression of both MMP9 and AQP4. miR-211-5p could target MMP9 directly in SVG P12 cells. Overexpression of miR-211-5p decreased the expression of MMP9, on the contrary, knockdown miR-211-5p through inhibitors increased the expression of both MMP9 and AQP4. Conclusion miR-211-5p inhibits the MMP9/AQP4 axis in human astrocyte cells, which represents a promising approach for the TBI treatment.


  • Neuroprotective effects of lentivirus‐mediated aquaporin‐4 gene silencing in rat model of traumatic brain injury

    by Bo Li, Meiping Wei, Xiangdong Wan, Zeshang Chen, Minghao Liu, Zhenzeng Fan, Lijun Yang

    Traumatic brain injury (TBI) is a common clinical condition caused by external force. Aquaporin-4 (AQP4) in astrocytes participates in the generation of cell swelling in TBI.This research explored ...


  • IMB5036, a novel pyridazinone compound, inhibits hepatocellular carcinoma growth and metastasis

    by Xing Lv, Qi Zhao, Yanqun Dong, Lijun Yang, Jianhua Gong, Yanbo Zheng, Tao Yang

    Summary Background Hepatocellular carcinoma (HCC) is one of the most common cancers with a high mortality rate due to metastasis and relapse. Purpose Here, we reported a small-molecule pyridazinone compound, designated as IMB5036. Its antitumor activity against HCC and underlying mechanism were studied. Methods In vitro cytotoxicity, apoptosis, DNA breaks, and cell motility assays were performed. Protein expression was analyzed by Western blot and microarray analysis. A xenograft tumor model in athymic mice was used to evaluate the antitumor activity. Results IMB5036 displayed potent cytotoxicity against various HCC cell lines. It caused double DNA breakages and induced cell death via apoptosis. It also significantly inhibited the motility of HCC cells. Western blot showed that IMB5036 induced the up-regulation of E-cadherin, while down-regulation of N-cadherin. The gene expression profile analysis and Western blot assay revealed that IMB5036 down-regulated the expression of Tau protein. Analysis of the TCGA dataset revealed that high expression of Tau decreased the survival rate of HCC patients. In vivo experiments proved that IMB5036 significantly inhibited the growth of HCC xenografts in athymic mice. Conclusions These results collectively demonstrate IMB5036 can be a promising therapeutic candidate for patients with HCC.


  • Secondary Metabolites and PI3K Inhibitory Activity of Colletotrichum gloeosporioides, a Fungal Endophyte of Uncaria rhynchophylla

    by Zhong-Duo Yang, Zhi-Jie Li, Jun-Wen Zhao, Jian-Hui Sun, Li-Jun Yang, Zong-Mei Shu

    In the present study, nine compounds (1–9) were isolated from Colletotrichum gloeosporioides (an endophytic fungus from Uncaria rhynchophylla) which was cultured in wheat bran medium. Their structures were elucidated as 4-Epi-14-hydroxy-10, 23-dihydro-24, 25-dehydroaflavinine (1), 10, 23-Dihydro-24,25 -dehydro-21–oxoaflavinine (2), Ergosterol (3), Ergosterol peroxide (4), Mellein (5), 4, 5-dihydroblumenol A (6), Colletotrichine A (7), Cyclo(L-leucyl-L-leucyl) (8), and Brevianamide F (9) based on NMR spectral data, as well as comparing with previous literature data. This is the first report about the isolation of compounds 1–2, 6, and 8–9 from Colletotrichum genus. All compounds were tested for their phosphoinositide 3-kinase (PI3Kα) inhibitory activity. Compounds 8 and 9 showed potent PI3K α inhibitory activity with IC50 values of 38.1 and 4.8 µM, respectively, while the other compounds showed very weak activity at a concentration of 20 µg/mL.


  • Open Access

    Clinical Features of Patients with Dysthymia in a Large Cohort of Han Chinese Women with Recurrent Major Depression

    by Wenqing Wu, Zhoubing Wang, Yan Wei, Guanghua Zhang, Shenxun Shi, Jingfang Gao, Youhui Li, Ming Tao, Kerang Zhang, Chengge Gao, et al.

    Dysthymia is a form of chronic mild depression that has a complex relationship with major depressive disorder (MDD). Here we investigate the role of environmental risk factors, including stressful life events and parenting style, in patients with both MDD and dysthymia. We ask whether these risk factors act in the same way in MDD with and without dysthymia. We examined the clinical features in 5,950 Han Chinese women with MDD between 30–60 years of age across China. We confirmed earlier results by replicating prior analyses in 3,950 new MDD cases. There were no significant differences between the two data sets. We identified sixteen stressful life events that significantly increase the risk of dysthymia, given the presence of MDD. Low parental warmth, from either mother or father, increases the risk of dysthymia. Highly threatening but short-lived threats (such as rape) are more specific for MDD than dysthymia. While for MDD more severe life events show the largest odds ratio versus controls, this was not seen for cases of MDD with or without dysthymia. There are increased rates of stressful life events in MDD with dysthymia, but the impact of life events on susceptibility to dysthymia with MDD differs from that seen for MDD alone. The pattern does not fit a simple dose-response relationship, suggesting that there are moderating factors involved in the relationship between environmental precipitants and the onset of dysthymia. It is possible that severe life events in childhood events index a general susceptibility to chronic depression, rather than acting specifically as risk factors for dysthymia.